
Blake Letney
Physician · Unitypoint Health
Credentials: · · ·
History
- 2025–Present
- 2022–2025

Research
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth
Journal of Clinical Investigation · 2019 · 33 citations
Scientific Reports · 2017 · 14 citations

1 paper · 1 as a resident

1 paper

1 paper

1 paper

1 paper

1 paper
- TO
1 paper